causal
Market underrates Kingspan's compounding and acquisitions
Nick believes analysts and the market underestimate Kingspan's compounding because sell-side models often exclude future acquisitions and underestimate organic growth as penetration rises.
causalpending
Speaker
Nick GriffinEvidence Quote
“people -- they simply don't model acquisitions generally over time, and they come in.”
Created: 11/13/2026, 12:21:00 AM
Your notes
Loading notes...